SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Nitinol Medical (NASDAQ: NMTI)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
18 0 0 NMTI
Emcee:  Caroline Type:  Unmoderated
JP Morgan brought Nitinol public in September. NMTI issued 3,000,000 shares.

The 3,000,000 shares sold for between 11 to 11 7/8, infusing the corporation with cash.

On 10/22/96, Jefferies & Co. Inc. initiated coverage of NMTL with a "buy."

On 11/20/96, the FDA cleared NMTI's Simon Nitinol Filter, "a thermal shape-memory nitinol vena cava filter designed to prevent pulmonary embolisms."

This is the FDA release article:
Wednesday November 20 11:08 AM EDT

Nitinol Medical Technologies Receives FDA Approval for Subclavian Implantation of its Simon Nitinol Filter

Company Continues to Offer Largest Number of Delivery Options to a $53 Million Worldwide Market

BOSTON, Nov. 20 /PRNewswire/ -- NITINOL MED today
announced that it has received 510(k) clearance from the Food and
Drug Administration ("FDA") to market its Simon Nitinol Filter
("SNF) for implantation through the subclavian vein in the shoulder.
The patented SNF, which received FDA approval in 1990, is a
thermal shape-memory nitinol vena cava filter designed to prevent
pulmonary embolisms. The approval of this additional access route
provides increased opportunity for physicians to adapt their existing
implantation techniques to individual patient conditions and anatomies.
With this approval, Nitinol Medical continues to provide the widest
variety of delivery options (leg, neck, arm and shoulder) for any vena
cava filter currently on the market.

A pulmonary embolism occurs when a blood clot lodges in the vessels
supplying blood to the lungs -- a condition which results in
approximately 125,000 to 150,000 deaths annually in the U.S. and
represented a $53 million worldwide market in 1995. Nitinol's SNF is
implanted using the Company's patented, catheter-based delivery
systems in a minimally invasive procedure. The SNF is distributed
worldwide by C.R. Bard, Inc., a leader in sales of minimally invasive
medical devices.

Thomas M. Tully, President & CEO of Nitinol Medical Technologies,
Inc., stated, "The clearance of the SNF for delivery through the
subclavian vein provides our customers with increased flexibility in
adapting the implantation of the device to each patient. No other
currently available vena cava filter provides such a wide range of
access options."

Nitinol Medical Technologies, Inc. designs, develops, and markets
innovative medical devices that utilize advanced materials and are
delivered by minimally invasive procedures. The Company's products
are designed to offer alternative approaches to existing complex
treatments, thereby reducing patient trauma, shortening procedure,
hospitalization and recovery times, and lowering overall treatment
costs. The Company's patented medical devices include
self-expanding stents, vena cava filters and septal repair devices.

To receive Nitinol's latest news release and other corporate documents
via FAX -- no cost -- please dial 1-800-PRO-INFO. Enter Nitinol's
ticker-NMTI.
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
18Insiders are buying NMTI Nmt Medical Inc Hanley Daniel F Md (Director) Buy 1jeeee4-2/18/2010
17<b>Migraine news:</b> www.investorshub.com/boards/read_msg.asp?messDewDiligence_on_SI-1/9/2005
16 Hi Caroline, NMTI reported an increase of 500% on Friday compared to that of thKIPPer-5/10/1998
15 Nup, haven't looked at it in a long time. Don't know why a stock shoulCaroline-4/9/1998
14 Is anybody out there following NMTI? The recent news on this stock seems positS. M. Kahn-4/9/1998
13 I have been watching NMTI for quite a while. I am a shareholder and I'm verRobert Andrew-3/14/1998
12 Nitinol Medical Technologies Announces Fourth Quarter and Full Year 1997 UnaudiVolsi Mimir-1/28/1998
11 Hey Kim someone else is watching NMTI besides us: NEW YORK, Jan 28 (Reuters) -Volsi Mimir-1/28/1998
10 Greetings Eddy, I do follow NMTI--but only its stock price and announcements. Kimrric-1/7/1998
9 PR Newswire, Thursday, November 13, 1997 at 16:40 BOSTON, Nov. 13 /PRNewswVolsi Mimir-11/14/1997
8 Reuters, Friday, November 14, 1997 at 17:07 BOSTON, Nov 14 (Reuters) - NitVolsi Mimir-11/14/1997
7 Thats interesting and good.. I called NMTI and they are going to overnite theirVolsi Mimir-11/7/1997
6 Eddy, I talked to a guy named Brian Gill yesterday, although I don't rememrt1^-11/7/1997
5 THANKS for respond I bought a little to play this AM but I don't have the Volsi Mimir-11/6/1997
4 Hi, eddy. NMTI's 3Q report is very positive. But the CEO is very honest andLee-11/6/1997
3 Hey any out here still follow NMTI??? If you do are you able to tell me the damVolsi Mimir-11/6/1997
2 Caroline, Robert. I too was intrigued by II's mention. See you here. KimKimrric-7/20/1997
1 Nice mention in 8-97 issue of Individual Investor - I'll begin following thRobert Busse-7/19/1997
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):